Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$287
-$8,105 QoQ
Shares Held
4
-94.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,394
of 1,408 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $7,829,403 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
223,068 | $7,733,767 | |
| 2 | HLN |
Haleon plc
|
5,397 | $50,354 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,228 | $41,604 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26 | $2,152 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
24 | $608 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
10 | $410 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
4 | $287 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
11 | $221 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287 | 4 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,392 | 71 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,939 | 79 | Shares | Sole | 2026-02-17 | |
| 2022-12-31 | $32,241 | 220 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||